Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lufax ADR | LU | Nov 26, 2024 | 2.30 | -1.29 |
Lululemon Athletica | LULU | Nov 26, 2024 | 318.84 | -2.41 |
Lulus Fashion Lounge | LVLU | Nov 26, 2024 | 1.23 | -2.38 |
Lumen Technologies | LUMN | Nov 26, 2024 | 7.65 | -1.67 |
Lument Finance Trust | LFT | Nov 26, 2024 | 2.58 | -0.39 |
Lument Finance Trust A Pref | LFT-A | Nov 26, 2024 | 22.65 | -2.33 |
Lumentum | LITE | Nov 26, 2024 | 86.98 | -0.25 |
Luminar Technologies A | LAZR | Nov 26, 2024 | 8.69 | -9.48 |
Lumos Pharma | LUMO | Nov 26, 2024 | 4.32 | +0.47 |
Luna Innovations | LUNA | Nov 26, 2024 | 1.82 | -3.19 |
Luokung Technology | LKCO | Nov 26, 2024 | 1.64 | +1.23 |
Luxfer | LXFR | Nov 26, 2024 | 14.34 | -1.10 |
LuxUrban Hotels | LUXH | Nov 26, 2024 | 1.27 | -9.29 |
Luxurban Hotels Pref | LUXHP | Nov 26, 2024 | 14.97 | +4.69 |
Lxp Industrial Trust | LXP | Nov 26, 2024 | 9.33 | -0.85 |
LXP Industrial Trust C Pref | LXP-C | Nov 26, 2024 | 49.90 | +0.19 |
Lyell Immunopharma | LYEL | Nov 26, 2024 | 0.92 | +1.18 |
Lyft A | LYFT | Nov 26, 2024 | 17.61 | -1.57 |
LyondellBasell Industries Nv A | LYB | Nov 26, 2024 | 82.14 | -2.28 |
Lyra Therapeutics | LYRA | Nov 26, 2024 | 0.20 | +4.37 |
Lytus Technologies | LYT | Nov 26, 2024 | 1.57 | -5.42 |
M&T Bank | MTB | Nov 26, 2024 | 220.75 | -0.54 |
M&T Bank ADR Prej J | MTB-J | Nov 26, 2024 | 27.22 | -0.18 |
M&T Bank H Pref | MTB-H | Nov 26, 2024 | 24.79 | -0.67 |
M-tron Industries | MPTI | Nov 26, 2024 | 66.53 | +0.70 |
M/I Homes | MHO | Nov 26, 2024 | 165.12 | -2.38 |
M3-Brigade Acquisition V | MBAVU | Nov 26, 2024 | 10.15 | +0.59 |
M3-Brigade Acquisition V | MBAV | Nov 26, 2024 | 10.05 | 0.00 |
Macerich | MAC | Nov 26, 2024 | 20.93 | +3.00 |
Mach Natural Resources LP | MNR | Nov 26, 2024 | 15.64 | -5.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.